UM1TR004921
Cooperative Agreement
Overview
Grant Description
Stanford Center for Clinical and Translational Research and Education - Abstract
The mission of the Stanford CTSA is to transform clinical, translational, and science of translation research and education (CTSRE) at Stanford and across the CTSA consortium. The Stanford CTSA’s programs in CTSRE have been designed to extend from the earliest stages of the translational pipeline to the “final mile” of implementation science at the patient and population level and to take full advantage of the rich research and educational resources available at Stanford University.
The overall goal is to make CTSRE more effective and efficient to serve the health needs of more individuals and more diverse populations. During the next seven years, the Stanford CTSA will achieve this goal by capitalizing on our greatest strengths, namely a) training the next generation of clinical, translational, and science of translation researchers; b) developing and implementing across all elements of our CTSA the principles of science of translation, including rigor and reproducibility (SPORR); team science; health policy; and research equity, accessibility, diversity, and inclusiveness (READI); and c) innovating data driven and clinical operational approaches to accelerate, scale, and diversify our translational research and science of translation research and educational efforts.
We aim to do this locally, regionally, and nationally in collaboration with our networks, including the CTSA consortium. To that end, our first overarching aim is to educate and train the next generation of investigators who make up the clinical and translational research “workforce” with the knowledge and skills in CTSRE to achieve the vision of translational medicine in the 21st century and to meet the opportunities and challenges of providing optimal, equitable healthcare delivery and access for all.
Our second overarching aim is to a) develop, optimize, and implement innovative data science and health informatics infrastructure, methods, and tools to promote analysis of large-scale real world data to serve as the platform for the conduct of CTSRE, accelerating the translation of discoveries into improved health outcomes; b) sustain, develop, enhance, and implement infrastructure, methods, services, and tools to support our entire CTSRE workforce locally and across the CTSA hub; c) imbue all elements of our Stanford CTSA with science of translation principles, including rigor and reproducibility (SPORR), team science, health policy, and research equity, accessibility, diversity and inclusiveness (READI) in support of our CTSRE mission.
Our third overarching aim is to maximize community engagement, team science, and diverse and inclusive approaches so our CTSRE products benefit all segments of the population. Finally, we aim to develop and employ innovative state-of-the-field evaluative approaches to determine the effectiveness of all our CTSRE efforts. With Stanford CTSA’s record of accomplishments to date, supportive institutional environment, well-developed infrastructure, integrated leadership, and expanding network of collaborators and community partners, we are well-positioned to execute on our vision for the next seven years.
The mission of the Stanford CTSA is to transform clinical, translational, and science of translation research and education (CTSRE) at Stanford and across the CTSA consortium. The Stanford CTSA’s programs in CTSRE have been designed to extend from the earliest stages of the translational pipeline to the “final mile” of implementation science at the patient and population level and to take full advantage of the rich research and educational resources available at Stanford University.
The overall goal is to make CTSRE more effective and efficient to serve the health needs of more individuals and more diverse populations. During the next seven years, the Stanford CTSA will achieve this goal by capitalizing on our greatest strengths, namely a) training the next generation of clinical, translational, and science of translation researchers; b) developing and implementing across all elements of our CTSA the principles of science of translation, including rigor and reproducibility (SPORR); team science; health policy; and research equity, accessibility, diversity, and inclusiveness (READI); and c) innovating data driven and clinical operational approaches to accelerate, scale, and diversify our translational research and science of translation research and educational efforts.
We aim to do this locally, regionally, and nationally in collaboration with our networks, including the CTSA consortium. To that end, our first overarching aim is to educate and train the next generation of investigators who make up the clinical and translational research “workforce” with the knowledge and skills in CTSRE to achieve the vision of translational medicine in the 21st century and to meet the opportunities and challenges of providing optimal, equitable healthcare delivery and access for all.
Our second overarching aim is to a) develop, optimize, and implement innovative data science and health informatics infrastructure, methods, and tools to promote analysis of large-scale real world data to serve as the platform for the conduct of CTSRE, accelerating the translation of discoveries into improved health outcomes; b) sustain, develop, enhance, and implement infrastructure, methods, services, and tools to support our entire CTSRE workforce locally and across the CTSA hub; c) imbue all elements of our Stanford CTSA with science of translation principles, including rigor and reproducibility (SPORR), team science, health policy, and research equity, accessibility, diversity and inclusiveness (READI) in support of our CTSRE mission.
Our third overarching aim is to maximize community engagement, team science, and diverse and inclusive approaches so our CTSRE products benefit all segments of the population. Finally, we aim to develop and employ innovative state-of-the-field evaluative approaches to determine the effectiveness of all our CTSRE efforts. With Stanford CTSA’s record of accomplishments to date, supportive institutional environment, well-developed infrastructure, integrated leadership, and expanding network of collaborators and community partners, we are well-positioned to execute on our vision for the next seven years.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Stanford,
California
94305
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 100% from $10,051,073 to $20,074,946.
The Leland Stanford Junior University was awarded
Transforming Clinical Translational Research Optimal Health Outcomes
Cooperative Agreement UM1TR004921
worth $20,074,946
from National Center for Advancing Translational Sciences in July 2024 with work to be completed primarily in Stanford California United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 7/21/25
Period of Performance
7/1/24
Start Date
6/30/31
End Date
Funding Split
$20.1M
Federal Obligation
$0.0
Non-Federal Obligation
$20.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UM1TR004921
Transaction History
Modifications to UM1TR004921
Additional Detail
Award ID FAIN
UM1TR004921
SAI Number
UM1TR004921-1101731739
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
HJD6G4D6TJY5
Awardee CAGE
1KN27
Performance District
CA-16
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Modified: 7/21/25